Hydration Room, a Southern California-based chain of IV and injection therapy clinics, opened a new location in Los Gatos as ...
Briumvi’s Phase 3 trial of an at-home injection has completed enrollment, testing an under-the-skin version against IV ...
Evidence gaps include limited topline safety granularity, unknown long-term follow-up and retreatment rates, and lack of ...
The trial met its primary endpoint, demonstrating a statistically significant 77% proptosis response rate at 24 weeks.
Cumberland Pharmaceuticals receives US FDA expanded indication approval for Caldolor injection: Nashville, Tennessee Friday, April 17, 2026, 17:00 Hrs [IST] Cumberland Pharmaceuti ...
Phase 3 trial evaluated two subcutaneous BRIUMVI dosing regimens; administration every 2 months or every 3 monthsTop-line data expected year-end ...
10d
Menopause products are having a hot minute. But doctors urge women to be wary of the marketing surge
DALLAS (AP) — Women suffering through the hot flashes, night sweats, mood changes and sleep problems that can come with ...
Long-term partnership secures high-quality active pharmaceutical ingredient supply for Lasix(R) ONYU and future pipeline products BURLINGTON, Mass. and VICENZA, Italy, April 15, 2026 /PRNewswire/ -- ...
Amgen Inc. (NASDAQ:AMGN) is one of the 7 Most Profitable Value Stocks to Buy Right Now. Amgen Inc. (NASDAQ:AMGN) is one of ...
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly ...
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced it has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication ...
Footage shows staff in Pakistan injecting without gloves and reusing syringes, but the hospital boss refuses to acknowledge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results